Stay updated with breaking news from Glsun Mall. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Following the strategic restructuring, Allakos reported that Lirentelimab failed in its Phase II studies for atopic dermatitis and chronic spontaneous urticaria. Read more.
Operator: Good afternoon. We will begin the MacroGenics 2023 First Quarter Corporate Progress and Financial Results Conference Call in just a moment.
Operator: Hello, and welcome to the AIM ImmunoTech Inaugural Fiscal Year 2022 Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode.
Operator: Good afternoon, ladies and gentlemen, and welcome to the Ventyx Biosciences Fourth Quarter and Full Year 2022 Earnings Conference Call.
Operator: Good day and thank you for standing by. Welcome to the Silence Therapeutics 2022 Annual Results Conference Call and Webcast. Please be advised that today's conference is being recorded.